今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2111次   下载 2016 本文二维码信息
码上扫一扫!
分享到: 微信 更多
冠心通脉胶囊对血管内皮功能的影响
柯于鹤1, 赵辉2, 陈烈2, 雷健1
1.武汉市第一医院心内科, 武汉 430022;2.湖北中医药大学, 武汉 430065
摘要:
[目的]探讨冠心通脉胶囊对冠心病患者血管内皮功能的影响及可能机制。[方法]60例冠心病患者被随机分为治疗组与对照组,各30例,治疗组在服用常规药物治疗的基础上加用冠心通脉胶囊,对照组则在常规药物治疗的基础上加用通心络胶囊,服用1个疗程后,比较两组患者血中内皮素(ET)、一氧化氮(NO)、高敏C反应蛋白(hs-CRP)的含量变化。[结果]治疗组、对照组在疗程结束后血中ET、hs-CRP含量均较治疗前明显降低(P<0.05);治疗组、对照组患者血中NO含量均较治疗前有明显升高(P<0.05)。治疗组和对照组之间无统计学差异(P>0.05)。[结论]冠心通脉胶囊可以升高患者NO,降低ET、hs-CRP,这可能是其保护血管内皮功能的机制之一。
关键词:  冠心病  冠心通脉胶囊  内皮功能  一氧化碳  高敏C-反应蛋白  内皮素
DOI:10.11656/j.issn.1672-1519.2011.05.11
分类号:
基金项目:武汉市卫生局资助项目(武卫[2007]43号)
Effect of Guanxintongmai capsule on blood vessel endothelium function
KE Yu-he1, ZHAO Hui2, CHEN Lie2
1.The First Hospital of Wuhan, Wuhan 430022, China;2.Hubei University of TCM, Wuhan 430065, China
Abstract:
[Objective] To study the mechanism of Guanxintongmai capsule on coronary heart disease patients.[Methods] The sixty patients with angina pectoris were randomly divided into two groups: treatment group(n=30) treated with Guanxintongmai capsule and the control group(n=30) with Tongxinluo capsule for four weeks.Then we analyzed the levels of ET/NO/hs-CRP in the patients between the two groups.[Results] The levels of NO in the treatment group and the control group were improved significantly.The levels of ET and hs-CRP in the treatment group and the control group were decreased significantly.There were no significant difference between the treatment group and control group.[Conclusion] Guanxintongmai capsule can significantly increase the level of NO and decrease the level of ET and hs-CRP.This is one of mechanism of protecting blood vessel endothelium function of guanxintaomai possibly.
Key words:  coronary heart disease  Guanxintongmai capsule  endothelial function  Nitric oxide  high sensitivity C-reactive protein  ET
关注公众号二维码